These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
Claude Fable 5 & Mythos 5: Key highlights from Anthropic’s latest launchAnthropic has launched Claude Fable 5, its most capable publicly available AI model, excelling in complex tasks and benchmarks. Alongside i...
Anthropic unveils Claude Fable 5, making a shift toward autonomous AI agentsAnthropic has launched Claude Fable 5 and Claude Mythos 5, introducing a new class of AI models designed for long-horizon, autonomous tasks...
Rs 1.8 crore job secured, zero distance travelled: Techie reveals his step-by-step strategy to land a high paying roleAn Indian software engineer, Kartik Modi, has gone viral after revealing how he secured a UK-based job worth around Rs 1.8 crore annually w...
Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
Govt to tap AI for mapping supply chains and investment clustersIndia's upcoming Statistical Business Register (SBR) will leverage AI and analytics to map supply chains, identify investment clusters, and...
India makes a quantum leap: India's first quantum-safe algorithm gets certified: Fortytwo Labs earns C-SAFE recognition from DSCIIndia has achieved a significant milestone with the independent evaluation and national recognition of its first domestically built quantum...
NPS withdrawal rules clarified: Postal department says pension body explains conditions to withdraw 100% NPS-Lite corpusNPS-Lite subscribers can now withdraw their entire accumulated pension wealth up to Rs 2 lakh as a lump sum, the Department of Posts announ...
Meta repeatedly pushes back new AI model release for developersMeta's new Muse Spark AI model API launch is nearing. While plans were pushed back, the company is now testing with early partners. Meta AI...
Brokers prepare rollout of algo trading tools for retail investorsMajor brokers are set to launch algorithmic trading tools for retail investors in the coming months, following enhanced regulatory clarity....
Claude AI down today for users: List of alternate AI apps you can use for best coding experienceClaude alternatives for coding: Claude AI experienced a significant outage on June 2, 2026, impacting multiple Anthropic services including...
Claude AI down: Anthropic AI chatbot faces partial outage as users report access issuesClaude AI Down Today: Claude AI users reported widespread access issues after Anthropic confirmed elevated error rates affecting multiple s...
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...